PubMed Health⌕ Search

PubMed · 8120696

Point-spread function for light scattered in the human ocular fundus.

Abstract

A model based on the framework of fundal reflectance model III is developed for the lateral spreading of light that emerges from the human ocular fundus after scattering in the choriocapillaris and the choroidal stroma. Blood in these layers is modeled as a forward scatterer, and the Kubelka-Munk diffuse radiation environment used for the choroid in model III is replaced by an arrangement of embedded reflectors that gives the same remittance. An equation is derived for the point-spread function, and sample calculations illustrate the dependence of the spreading function on retinal site and wavelength and identify the characteristic influences of the long-wavelength edge of the 575-nm oxyhemoglobin absorption band and the choroidal melanin.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

I J Hodgkinson, P B Greer, A C Molteno. 1994. Point-spread function for light scattered in the human ocular fundus.. https://doi.org/10.1364/josaa.11.000479

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Theoretical estimation of retinal oxygenation during retinal detachment.

The aim of the present work was to simulate the oxygenation of the whole retina during different degrees of retinal detachment. A differential equation describing the oxygenation of the whole retina, at different degrees of detachment, was set up and solved numerically. The results show that the choroid can supply the outer retina with a fairly large amount of oxygen as long as the detachment height is lower than about 1mm. This study thus supports the view that hyperoxia may well prove to be clinically beneficial.

Choroid↗

Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions.

Ocular angiogenesis may lead to visual impairment and even irreversible blindness in people of all ages worldwide. Choroidal neovascularization (CNV), a major clinical complication of ocular angiogenesis, is an important cause of vision loss that affects a large number of people. Physiological angiogenesis is tightly controlled by a balance in the expression of angiogenic and anti-angiogenic factors. While the underlying mechanism of CNV is complex, it is attributed to an upset in this balance. The vascular endothelial growth factor (VEGF) is essential in the development of CNV as one of the most potent angiogenic stimulators and vascular permeability factors. Pigment epithelium derived factor (PEDF) is a strong inhibitor of angiogenesis with high neuroprotective effects. VEGF and PEDF both possess multiple biological activities and functions that affect a large variety of tissue cells of the eye and other organs. Inappropriate expression levels are associated with many diseases involving neovascularization. This paper describes the unbalanced expressions of VEGF and PEDF as a cause of CNV. Based on the respective angiogenic and anti-angiogenic properties of VEGF and PEDF, experimental models have been devised to genetically reduce VEGF or enhance PEDF to achieve therapeutic effects. Gene therapy for CNV is promising and is under intensive research.

Choroid↗